The development of medical knowledge and the improvement of patients’ quality of life are among the objectives of the J.-Armand Bombardier Foundation in the healthcare sector. Particular attention is paid to people affected by cancer. Dr. Mark Basik’s laboratory seeks to understand how cancer cells adapt and resist chemotherapy, in order to better treat resistant breast cancers. This research is having an unprecedented impact on patients. Dr. Basik’s team is the only one in Canada to offer new treatment options to oncologists for aggressive cancers. It is essential to support the continuation of this research, which offers therapeutic alternatives and new hope to patients.